Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of acute kidney injury in head and neck cancer patients treated with weekly versus every-three-weeks cisplatin during concurrent chemoradiation
TCTR20241009005Completed
- Sponsor
- Maharat Nakhon Ratchasima Hospital
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cisplatin in head and neck cancer (HNC) and acute kidney failure (AKF) (2 arms), sponsored by Maharat Nakhon Ratchasima Hospital. Primary endpoint: Prevalence of acute kidney injury. Started Nov 2023; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck cancer (HNC)acute kidney failure (AKF)
Beyond the preview
Go deeper on TCTR20241009005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241009005.